Cancer multidrug-resistance reversal by ABCB1 inhibition: A recent update
K Engle, G Kumar - European journal of medicinal chemistry, 2022 - Elsevier
Chemotherapy is one of the most common treatments for cancer that uses one or more anti-
cancer drugs as a part of the standardized chemotherapy regimen. Cytotoxic chemicals …
cancer drugs as a part of the standardized chemotherapy regimen. Cytotoxic chemicals …
Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters
Cancer cells frequently display intrinsic or acquired resistance to chemically diverse
anticancer drugs, limiting therapeutic success. Among the main mechanisms of this …
anticancer drugs, limiting therapeutic success. Among the main mechanisms of this …
Chemical molecular‐based approach to overcome multidrug resistance in cancer by targeting P‐glycoprotein (P‐gp)
H Zhang, H Xu, CR Ashby Jr, YG Assaraf… - Medicinal research …, 2021 - Wiley Online Library
Multidrug resistance (MDR) remains one of the major impediments for efficacious cancer
chemotherapy. Increased efflux of multiple chemotherapeutic drugs by transmembrane ATP …
chemotherapy. Increased efflux of multiple chemotherapeutic drugs by transmembrane ATP …
ATP‐binding cassette (ABC) transporters in cancer: A review of recent updates
The ATP‐binding cassette (ABC) transporter superfamily is one of the largest membrane
protein families existing in wide spectrum of organisms from prokaryotes to human. ABC …
protein families existing in wide spectrum of organisms from prokaryotes to human. ABC …
[HTML][HTML] Multidrug resistance of cancer cells and the vital role of P-glycoprotein
P-glycoprotein (P-gp) is a major factor in the multidrug resistance phenotype in cancer cells.
P-gp is a protein that regulates the ATP-dependent efflux of a wide range of anticancer …
P-gp is a protein that regulates the ATP-dependent efflux of a wide range of anticancer …
Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1-and ABCG2-overexpressing cancer cells
Overexpression of ATP-binding cassette (ABC) transporters is one of the most important
mechanisms responsible for the development of multidrug resistance (MDR). Selonsertib, a …
mechanisms responsible for the development of multidrug resistance (MDR). Selonsertib, a …
Cell signaling and cancer: a mechanistic insight into drug resistance
Drug resistance is a major setback for advanced therapeutics in multiple cancers. The
increasing prevalence of this resistance is a growing concern and bitter headache for the …
increasing prevalence of this resistance is a growing concern and bitter headache for the …
Perspectives on drug repurposing to overcome cancer multidrug resistance mediated by ABCB1 and ABCG2
CP Wu, SH Hsiao, YS Wu - Drug Resistance Updates, 2023 - Elsevier
The overexpression of the human ATP-binding cassette (ABC) transporters in cancer cells is
a common mechanism involved in developing multidrug resistance (MDR). Unfortunately …
a common mechanism involved in developing multidrug resistance (MDR). Unfortunately …
[HTML][HTML] Adagrasib, a KRAS G12C inhibitor, reverses the multidrug resistance mediated by ABCB1 in vitro and in vivo
Y Zhang, C Li, C Xia, KK Wah To, Z Guo, C Ren… - Cell Communication and …, 2022 - Springer
Background Multidrug resistance (MDR) is a complex phenomenon that frequently leads to
chemotherapy failure during cancer treatment. The overexpression of ATP-binding cassette …
chemotherapy failure during cancer treatment. The overexpression of ATP-binding cassette …
[HTML][HTML] The AKT inhibitor, MK-2206, attenuates ABCG2-mediated drug resistance in lung and colon cancer cells
Introduction: The overexpression of ATP-binding cassette (ABC) transporters, ABCB1 and
ABCG2, are two of the major mediators of multidrug resistance (MDR) in cancers. Although …
ABCG2, are two of the major mediators of multidrug resistance (MDR) in cancers. Although …